+
Malaysian Genomes in Phase I
Menu
The MyGenom Project is an effort to understand the genetic makeup of Malaysians. It’s our country’s first large-scale study of population genomics, which means sequencing the DNA of Malaysian citizens from different races and ethnicities. In Phase I, 2,400 genomes will be sequenced from healthy Malaysian individuals, with the goal of reaching 10,000 genomes in Phase II. Over time, this project will create a Malaysia reference genomic dataset that reflects the diversity of our population and will be the key to bringing Precision Medicine to Malaysia.
Malaysian Genomes in Phase I
Malaysian Genomes in Phase I & II
To identify the genetic basis of many diseases. By mapping the entire human genome, scientists can pinpoint specific genes
associated with conditions such as cystic fibrosis, sickle cell anemia, and various forms of cancer.
To study how genes affect a person's response to drugs. This knowledge helps in prescribing medications that are more likely to be effective for specific individuals based on their genetic profiles.
Treatments can be tailored based on an individual's genetic makeup. This approach improves treatment efficacy and reduces side effects, as therapies can be customized to the patient's genetic profile.
Can help inform public health initiatives by identifying populations at risk for certain genetic disorders and guiding screening programs for early detection and prevention.
Under the National Biotechnology Policy 2.0, Flagship Program 4 has outlined the use of biologics, omics technologies, and targeted therapies to improve health through precision and personalized medicine.
Watch Video
